Hyperglycemia leads to poorer clinical outcomes, with increased morbidity and mortality in both critically ill and non-critically ill people. Improving blood glucose levels reduces length of hospital stay, systemic infections and short- and long-term mortality. Egyptian physicians evaluated the efficacy of insulin degludec compared to insulin glargine and regular insulin in controlling blood glucose levels.
You May Also Like
- Study on tinnitus in everyday practice
ENT specialists rely on Ginkgo biloba
- Hodgkin's lymphoma
No more transplants for relapsed or refractory HL in the future?
- Gram-negative foot infection
Not to be taken lightly
- Severe asthma
Anti-IL-5/-5Rα biologics impress in the real world
- Significance, diagnostics and treatment options for cardiology practice
Coronary artery spasm and atherosclerosis
- Smoldering multiple myeloma
Daratumumab delays progression in smoldering multiple myeloma
- Invitation to the 12th IBD Roadshow | June 23-25, 2025 | with Professor Bruce Sands
Acceleration in IBD Treatment: How early and holistic care leads to better outcomes
- Chronic hand eczema